Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
- USD | -.--% | -.--% | -.--% |
Attività
Vendite per attività
HKD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Biopharmaceutical
100,0
%
| 3 738 | 100,0 % | 5 961 | 100,0 % | +59,47% |
Vendite per regione
HKD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
China
89,2
%
| 3 303 | 88,4 % | 5 316 | 89,2 % | +60,92% |
North America
5,8
%
| 169 | 4,5 % | 348 | 5,8 % | +106,21% |
Asia Pacific (excluding China)
3,6
%
| 208 | 5,6 % | 214 | 3,6 % | +3,00% |
Europe
1,0
%
| 58 | 1,6 % | 62 | 1,0 % | +6,83% |
South America
0,4
%
| - | - | 21 | 0,4 % | - |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Wei Dong Jiang
FOU | Founder | - | 01/12/09 |
Jun Zhu
CEO | Chief Executive Officer | 46 | 30/11/21 |
Wei Huang
PSD | President | 56 | 01/10/20 |
Wen Jie Zhang
CHM | Chairman | 57 | 01/03/19 |
Simon Hsu
CTO | Chief Tech/Sci/R&D Officer | - | - |
Miao Jie Chen
CMP | Compliance Officer | 41 | - |
Ye Xing Yuan
BRD | Director/Board Member | 39 | 01/01/23 |
Jin Li
LAW | General Counsel | - | 13/09/21 |
Jing Li
PRN | Corporate Officer/Principal | - | - |
Ping Cao
PRN | Corporate Officer/Principal | - | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Qi Yu Chen
BRD | Director/Board Member | 52 | 15/01/13 |
Tak Young So
BRD | Director/Board Member | 54 | 02/09/19 |
Xiao Hui Guan
BRD | Director/Board Member | 53 | 24/12/18 |
Yi Fang Wu
BRD | Director/Board Member | 54 | 12/06/15 |
De Yong Wen
BRD | Director/Board Member | 52 | 28/07/22 |
Guo Ping Zhao
BRD | Director/Board Member | 75 | 02/09/19 |
Rong Li Feng
CHM | Chairman | 49 | 21/04/20 |
De Li Kong
BRD | Director/Board Member | 50 | 01/08/16 |
Ye Xing Yuan
BRD | Director/Board Member | 39 | 01/01/23 |
Xing Li Wang
BRD | Director/Board Member | 61 | 28/08/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 380 066 312 | 0 | 0 | 15,03 % |
Azione B | 1 | 163 428 541 | 81 687 447 ( 49,98 %) | 0 |
Coordinate società
Shanghai Henlius Biotech, Inc.
Innov Tower 1801 Hongmei Road, Xuhui District
200233, Shanghai
+
http://www.henlius.comSettore
Vendite per regione
Revisioni EPS
Utili annuali - Indice di sorpresa
Variaz. 1 gen. | Capi. | |
---|---|---|
-2,29% | 89,38 Mrd | |
-3,95% | 37,92 Mrd | |
-13,07% | 32,04 Mrd | |
+63,05% | 26,03 Mrd | |
-22,14% | 14,14 Mrd | |
-7,96% | 12,88 Mrd | |
-9,33% | 11,77 Mrd | |
-46,33% | 10,85 Mrd | |
+5,77% | 8,92 Mrd |
- Borsa valori
- Azioni
- Azione 2696
- Azione SGBCF
- Società Shanghai Henlius Biotech, Inc.